Applied dna announces fourth quarter and fiscal year 2022 financial results

Stony brook, n.y.--( business wire )--applied dna sciences, inc. (nasdaq: apdn) (“applied dna” or the “company”), a leader in pcr-based dna technologies, today announced consolidated financial results for the fourth quarter and fiscal year ended september 30, 2022.

APDN Ratings Summary

APDN Quant Ranking